*ALEXION TO BUY SYNAGEVA IN DEAL VALUED AT $8.4B NET OF CASH
Alert: HALISTER Source: BN (Bloomberg News)
Tickers ALXN US (Alexion Pharmaceuticals Inc)
People David Hallal (Alexion Pharmaceuticals Inc) Felix Baker (Baker Brothers Advisors LLC) Leonard Bell (Alexion Pharmaceuticals Inc) Sanj Patel (Synageva Biopharma Corp)
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283